[{"address1": "3891 Ranchero Drive", "address2": "Suite 150", "city": "Ann Arbor", "state": "MI", "zip": "48108", "country": "United States", "phone": "734 887 3903", "website": "https://www.esperion.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. The company's products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. The company has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.", "fullTimeEmployees": 240, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sheldon L. Koenig", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 1278804, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric J. Warren R.Ph.", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 718859, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin  Halladay M.B.A.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Glenn P. Brame", "age": 66, "title": "Chief Technical Operations Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin O. Looker J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 550350, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Tiffany  Aldrich M.B.A.", "title": "Associate Director of Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betty Jean Swartz", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 7, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.66, "open": 1.66, "dayLow": 1.64, "dayHigh": 1.71, "regularMarketPreviousClose": 1.66, "regularMarketOpen": 1.66, "regularMarketDayLow": 1.64, "regularMarketDayHigh": 1.71, "payoutRatio": 0.0, "beta": 1.009, "forwardPE": 8.5, "volume": 2128676, "regularMarketVolume": 2128676, "averageVolume": 5568259, "averageVolume10days": 2471200, "averageDailyVolume10Day": 2471200, "bid": 1.67, "ask": 1.72, "bidSize": 10, "askSize": 17, "marketCap": 334959520, "fiftyTwoWeekLow": 1.58, "fiftyTwoWeekHigh": 3.94, "priceToSalesTrailing12Months": 1.1337227, "fiftyDayAverage": 2.0456, "twoHundredDayAverage": 2.1787, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 459204800, "profitMargins": -0.29369, "floatShares": 195557407, "sharesOutstanding": 197035008, "sharesShort": 28100794, "sharesShortPriorMonth": 33978548, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1426, "heldPercentInsiders": 0.00382, "heldPercentInstitutions": 0.66133004, "shortRatio": 6.49, "shortPercentOfFloat": 0.143, "impliedSharesOutstanding": 197035008, "bookValue": -1.894, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -86771000, "trailingEps": -0.67, "forwardEps": 0.2, "enterpriseToRevenue": 1.554, "enterpriseToEbitda": 27.836, "52WeekChange": -0.3196721, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 1.7, "targetHighPrice": 16.0, "targetLowPrice": 2.05, "targetMeanPrice": 6.75625, "targetMedianPrice": 5.5, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 144716992, "totalCashPerShare": 0.734, "ebitda": 16497000, "totalDebt": 268961984, "quickRatio": 1.281, "currentRatio": 1.854, "totalRevenue": 295451008, "revenuePerShare": 1.776, "returnOnAssets": 0.03842, "grossProfits": 188026000, "freeCashflow": -8951375, "operatingCashflow": -25758000, "revenueGrowth": 0.52, "grossMargins": 0.6364, "ebitdaMargins": 0.05584, "operatingMargins": -0.31039, "financialCurrency": "USD", "symbol": "ESPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Esperion Therapeutics, Inc.", "longName": "Esperion Therapeutics, Inc.", "exchange": "NGM", "messageBoardId": "finmb_28236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1372253400000, "corporateActions": [], "postMarketTime": 1740790702, "regularMarketTime": 1740776402, "postMarketChangePercent": 1.14705, "postMarketPrice": 1.7195, "postMarketChange": 0.0194999, "regularMarketChange": 0.04000008, "regularMarketDayRange": "1.64 - 1.71", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 5568259, "fiftyTwoWeekLowChange": 0.120000005, "fiftyTwoWeekLowChangePercent": 0.07594937, "fiftyTwoWeekRange": "1.58 - 3.94", "fiftyTwoWeekHighChange": -2.24, "fiftyTwoWeekHighChangePercent": -0.56852794, "fiftyTwoWeekChangePercent": -31.96721, "earningsTimestamp": 1741095000, "earningsTimestampStart": 1741095000, "earningsTimestampEnd": 1741095000, "earningsCallTimestampStart": 1741093200, "earningsCallTimestampEnd": 1741093200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.67, "epsForward": 0.2, "epsCurrentYear": -0.33, "priceEpsCurrentYear": -5.151515, "fiftyDayAverageChange": -0.3455999, "fiftyDayAverageChangePercent": -0.16894794, "twoHundredDayAverageChange": -0.47869992, "twoHundredDayAverageChangePercent": -0.21971814, "priceToBook": -0.89757127, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 2.4096434, "regularMarketPrice": 1.7, "displayName": "Esperion Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]